USANA Health Sciences, Inc. (USNA)
Consumer Defensive
- Fundamental
- 3
- Sentiment
- 2
- Technical
- 3
Do Nothing: qualitativeScore is 2 (below the required floor of 3; the upstream qualitative screen flagged sharply deteriorating sentiment after the Q2 earnings miss and guidance cut) and the 20-day average dollar volume (~$3.76M) is below the $5M liquidity floor; no chart pattern overrides either hard block.
Company overview
USANA Health Sciences, Inc. develops, manufactures, and sells nutritional, personal care, and skincare products across the Asia Pacific, Americas, and Europe. The company operates through Core nutritional and Hiya Direct-To-Consumer segments, offering products like supplements, meal replacements, and skincare regimens. USANA distributes its products via retail, subscription, direct selling, and online channels.
Fundamental
fairUSANA's strong liquidity is offset by declining profitability and a recent impairment, leading to mixed fundamentals.
USANA has a strong liquidity cushion and appears inexpensive on enterprise-value multiples, but profitability has compressed dramatically (FY2025 EPS $0.58 vs $3.30 in FY2023) and the latest quarter included a material Hiya impairment with lowered FY2026 guidance. Net cash and buybacks help, but the near-term thesis depends on stabilizing customer trends and improving performance in the acquired brands.
Sentiment
weakSentiment is negative following a Q2 earnings miss, with no positive catalysts or retail interest.
Bearish Q2 2026 earnings print (announced 2026-08-04) dominates: net loss, revenue miss, and lowered key-brand guidance drove a ~29% selloff, with a fresh sell-side downgrade the next day; sentiment delta is determinately negative (≈ +0.06 → ≈ -0.25) and the legal screen is clean. Moderate red-flag cap applied (sentiment deteriorating sharply with no offsetting bullish catalyst); setup is weak and bearish-tilted.
Technical
fairTechnicals show early signs of stabilization but remain below key moving averages, indicating no confirmed reversal.
Chart quality score 3 (mixed). Bullish elements: two higher lows (12.57 on 08-18, 13.44 on 08-27), price back above the EMA9 (13.98), WMA9 (13.89) and WMA21 (13.87), RSI14 recovering from 26.76 to 37.60, Williams %R at -15.50 near the top of its 14-day range, and the MACD histogram at +0.27 and rising for eight straight sessions. Bearish elements: price still below the SMA20 (14.31), SMA50 (18.68), SMA200 (19.21) and EMA21 (15.17); the MACD line remains -1.47; ADX14 at 24.08 is below the 25 trend-strength threshold; and daily dollar volume is thin (~$3.76M 20-day average). Early stabilization within a downtrend, not yet a confirmed reversal.
You’re looking at 2026-09-01 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Consumer Defensive
Not financial advice. For informational and educational purposes only.